Digital pathology firm Paige has joined forces with Microsoft, with the two firms working to transform cancer diagnosis and patient care by building the world’s largest image-based artificial intelligence (AI) models for digital pathology and oncology.
Paige, a global leader in end-to-end digital pathology solutions and clinical AI, developed the first Large Foundation Model using over one billion images from half a million pathology slides across multiple cancer types. Paige - with the help of Microsoft - is developing a new AI model that is larger than any other image-based AI model existing today, configured with billions of parameters. This model assists in capturing the subtle complexities of cancer and serves as the cornerstone for the next generation of clinical applications and computational biomarkers that push the boundaries of oncology and pathology.
“Paige has been at the forefront of innovation since its inception, and by combining Microsoft’s expertise and enormous compute power with Paige’s deep expertise in AI, technology, and digital pathology, we strongly believe we will significantly advance the state-of-the-art in cancer imaging. Through the development of this model, we will help improve the lives of the millions of people who are affected by cancer every day,” said Razik Yousfi, SVP of Technology at Paige.
In this next phase of development, Paige is incorporating up to four million digitised microscopy slides across multiple types of cancer from its unmatched petabyte-scale archive of clinical data. Paige will utilise Microsoft’s advanced supercomputing infrastructure to train the technology at scale and ultimately deploy it to hospitals and laboratories across the globe using Azure.
“Paige technology already goes beyond what is humanly possible today and helps physicians deliver better cancer care with AI support. By realising the potential of generative AI at unprecedented scale, the Paige model collaboration with Microsoft is a milestone in the history of oncology. It opens a window into the microscopic world with extraordinary fidelity, allowing for not only much higher accuracy but completely novel capabilities,” said Thomas Fuchs, Founder and Chief Scientist at Paige.